A hypothalamic digoxin mediated model for conscious and subliminal perception

Journal of Neural Transmission

Volumn 108, Issue 7, 2001, Pages 855-868

  Ravi Kumar, A ^a   Kurup, P A ^b  

^a Department of Neurology

^b UNIVERSITY OF KERALA   (India)

Author keywords

Digoxin; Dolichol; Schizophrenia; Ubiquinone

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DIGOXIN; DOLICHOL; EXCITOTOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINOLINIC ACID; SEROTONIN; TRYPTOPHAN; UBIQUINONE;

ADULT; ARTICLE; AUTOIMMUNITY; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CONSCIOUSNESS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HYPERPOLARIZATION; HYPOMAGNESEMIA; HYPOTHALAMUS; PATHOGENESIS; PERCEPTION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN TRANSPORT; SCHIZOPHRENIA;

ADULT; CONSCIOUSNESS; DIGOXIN; DOLICHOL; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPOTHALAMUS; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; SCHIZOPHRENIA; SUBLIMINAL STIMULATION;

EID: 0034915142     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020170035     Document Type: Article

References (56)

1. Linking mind and brain in the study of mental illnesses: A project for a scientific psychopathology
2. Endogenous alkaloids in the brain of rats loaded with tyrosine/tryptophan and in the serum of patients of neurodegenerative and psychiatric disorders
3. Identification and estimation of endogenous digoxin in biological fluids and tissues by TLC and HPLC
4. Death receptors signalling and modulation
5. Schizophrenia and affective disorders. Are they genetically linked
6. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative disease
7. Cerebrospinal fluid monoamine metabolites in depression and schizophrenia
8. Error in the determination of tryptophan by the method of Denkala and Dewey. A revised procedure
9. Understanding the inner voices
10. Neurotransmission keeping synapses up to speed
11. Medical progress in schizophrenia
12. Possible role of endogenous ouabain like compounds in the pathophysiology of bipolar illness
13. Decreased hippocampal expression of glutamate receptor gene in schizophrenia
14. Biological markers of depression
15. Rapid method for the determination of 5-hydroxy tryptamine and 5-hydroxy indoleacetic acid in certain regions of rat brain
16. T-cell development and transmembrane signalling. Changing biological responses through a unchanging receptor
17. Blood-brain movements of tryptophan and tyrosine in manic depressive illness and schizophrenia
18. Regulation of the mevalonate pathway
19. Mitochondria and apoptosis
20. Anatomy and physiology of glutamate in CNS
21. + ATPase activity in essential hypertension
22. Sodium pump regulation by endogenous inhibition
23. Absorption of a novel prodrug of DOPA
24. 10 level in schizophrenia patients
25. Nutrition, health and antioxidants
26. Prenatal developmental disturbance in the limbic allocortex in schizophrenics
27. Effect of magnesium deficiency on the metabolism of glycosaminoglycans in rats
28. Basic cellular neurophysiology
29. Brain tryptophan metabolism in schizophrenia - A postmortem study of metabolites of the serotonin and kynurenine pathways in schizophrenia and control subjects
30. Neuropathology of the persistent vegetative state
31. Alpha-L-Fucose a potentially critical molecule in pathologic processes including neoplasia
32. Changes in the glycosaminoglycans and glycoproteins in the rat brain during protein calorie malnutrition
33. Single neuron can initiate synchronised population discharges in hippocampus
34. Separation of some neutral lipids by normal phase high performance liquid chromatography on a cyanopropyl column: Ubiquinone, dolichol and cholesterol levels in sheep liver
35. Viral strategies for immune evasion
36. Estimation of HMG CoA reductase activity
37. + ATPase content
38. Isoprenoid pathway and free radical generation and damage in neuropsychiatric disorders
39. Alteration in glycoconjugate metabolism in CNS disorders - Role of isoprenoid pathway
40. Free radicals and schizophrenia
41. Excitatory amino acids and ALS, an update
42. +ATPase in schizophrenia and major depressive disorder
43. A lesson from secretory granules
44. Digoxin toxicity presenting as altered mental status in patients with severe chronic obstructive lung disease
45. Possible aetiology of schizophrenia - Progressive damage to the noradrenergic reward system by 6-hydroxy dopamine
46. The chemical estimation of catecholamines and their metabolites in body fluids and tissue extracts
47. Vesicular transport
48. Flourimetric method for Tyrosine
49. Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices
50. Estimation of phospholipids